Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Journal of Urology|March 23, 2010
Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trialSender Herschorn, Lynn Stothers, Kevin Carlson, et al.Urology|June 18, 2013
A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladderSender Herschorn, Jack Barkin, David Castro-Diaz, et al.Clinical Therapeutics|November 18, 2005
Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysisDimitrios G Hatzichristou, Philip Aliotta, Stephen Auerbach, et al.Urology|April 19, 2005
Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitisJ Curtis Nickel, Jack Barkin, John Forrest, et al.BJU International|September 30, 2016
24-month durability after crossover to the prostatic urethral lift from randomised, blinded shamDaniel Rukstalis, Prem Rashid, William K Bogache, et al.Urology|March 7, 2002
Effect of pentosan polysulfate therapy on intravesical potassium sensitivityC Lowell Parsons, John Forrest, J Curtis Nickel, et al.The Journal of Urology|June 7, 2006
Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuriaMichael F Sarosdy, Paul R Kahn, Mark D Ziffer, et al.The Journal of Urology|April 12, 2016
Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected]Scott MacDiarmid, Salman Al-Shukri, Jack Barkin, et al.The Canadian Journal of Urology|June 26, 2017
Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. studyClaus G Roehrborn, Jack Barkin, Steven N Gange, et al.The Canadian Journal of Urology|June 13, 2015
Three year results of the prostatic urethral L.I.F.T. studyClaus G Roehrborn, Daniel B Rukstalis, Jack Barkin, et al.Pageof 7